1. Physiologically based pharmacokinetic model combined with reverse dose method to study the nephrotoxic tolerance dose of tacrolimus
   Limin Cai et al, 2023, Archives of Toxicology CrossRef
2. CXC Chemokine Receptor 2 Accelerates Tubular Cell Senescence and Renal Fibrosis via β-Catenin-Induced Mitochondrial Dysfunction
   Ping Meng et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
3. CXC chemokine receptor 7 ameliorates renal fibrosis by inhibiting β-catenin signaling and epithelial-to-mesenchymal transition in tubular epithelial cells
   Ping Meng et al, 2024, Renal Failure CrossRef
4. Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosis
   Adaku C. Ume et al, 2023, American Journal of Physiology-Renal Physiology CrossRef
5. A Review of CXCL1 in Cardiac Fibrosis
   Cheng-Long Wu et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
6. Linagliptin Mitigates TGF-β1 Mediated Epithelial–Mesenchymal Transition in Tacrolimus-Induced Renal Interstitial Fibrosis via Smad/ERK/P38 and HIF-1α/LOXL2 Signaling Pathways
   Mohamed E. Nady et al, 2024, Biological and Pharmaceutical Bulletin CrossRef
7. Optimizing the initial tacrolimus dosage in Chinese children with lung transplantation within normal hematocrit levels
   Ke Hu et al, 2024, Frontiers in Pediatrics CrossRef